
Meridian Bioscience VIVO
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience Kurzfristige Verbindlichkeiten 2011-2026 | VIVO
Kurzfristige Verbindlichkeiten Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 58 M | 47.2 M | 52.5 M | 20.9 M | 24.2 M | 22.9 M | 22.6 M | 15.3 M | 13.7 M | 21.7 M | 18.5 M | 15.3 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 58 M | 13.7 M | 27.7 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
1.71 B | $ 117.74 | -1.68 % | $ 35.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
372 M | $ 19.95 | -2.97 % | $ 211 M | ||
|
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
89.8 M | $ 22.11 | 25.81 % | $ 1.18 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
3.54 M | $ 1.42 | - | $ 1.89 M | ||
|
Castle Biosciences
CSTL
|
49.4 M | $ 24.49 | -0.53 % | $ 680 M | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | ||
|
Charles River Laboratories International
CRL
|
1.12 B | $ 179.73 | -0.51 % | $ 8.91 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
6.81 B | $ 194.65 | -1.74 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
5.1 M | $ 1.93 | -12.09 % | $ 8.54 M | ||
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
1.55 B | $ 130.0 | -1.71 % | $ 20.7 B | ||
|
Medpace Holdings
MEDP
|
1.34 B | $ 521.19 | 0.51 % | $ 15 B | ||
|
Fulgent Genetics
FLGT
|
72.9 M | $ 16.04 | -0.8 % | $ 485 M | ||
|
NeoGenomics
NEO
|
88.3 M | $ 8.39 | -3.34 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
174 M | $ 9.18 | -2.55 % | $ 1.99 B | ||
|
Guardant Health
GH
|
303 M | $ 85.27 | 0.48 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
1.97 M | $ 2.84 | -3.07 % | $ 92.2 K | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.19 | 4.03 % | $ 5.03 M | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 115.89 | -0.52 % | $ 9.56 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 267.91 | 0.38 % | $ 22.3 B | ||
|
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
44.2 M | $ 122.94 | -0.43 % | $ 5.75 B | ||
|
Senseonics Holdings
SENS
|
24.3 M | $ 6.78 | -1.74 % | $ 283 M | ||
|
Myriad Genetics
MYGN
|
134 M | $ 5.16 | -0.67 % | $ 478 M | ||
|
Lantheus Holdings
LNTH
|
333 M | $ 83.51 | -0.51 % | $ 5.64 B | ||
|
Soleno Therapeutics
SLNO
|
61.4 M | $ 52.62 | 0.1 % | $ 2.67 B | ||
|
Neuronetics
STIM
|
30.5 M | $ 1.36 | -2.52 % | $ 89.7 M | ||
|
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 193.55 | 1.16 % | $ 21.5 B | ||
|
ENDRA Life Sciences
NDRA
|
751 K | $ 5.2 | 1.17 % | $ 4.09 M | ||
|
Thermo Fisher Scientific
TMO
|
15.2 B | $ 522.74 | -1.65 % | $ 197 B | ||
|
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | ||
|
National Research Corporation
NRC
|
36.6 M | $ 17.81 | -0.17 % | $ 399 M |